Melbourne has placed the winning bid to host the International College of Neuropsychopharmacology (CINP) World Congress on 16-19 June 2025. This will mark the second time the event will take place in the city, underscoring its reputation as a leading global hub for medical research and innovation.
Acknowledged as a pivotal event in its field, CINP’s Annual Congress serves as a platform for the global exchange of knowledge between clinicians and researchers, connecting biologists, researchers, psychiatrists, neurologists, pharmacologists and psychologists from over 50 countries.
“Melbourne has a strong track record in delivering world-class business events and we look forward to hosting the CINP World Congress in Neuropsychopharmacology in 2025,” says Victorian Minister for Tourism, Sport and Major Events Steve Dimopoulos. “Business events showcase Melbourne to visitors from near and far, while supporting local jobs, businesses and industry development.”
CINP2025 which will be held in conjunction with the Annual Meeting of the Asian College of Neuropsychopharmacology, is expected to draw over 1,000 of the world’s leading experts to Melbourne and will enable clinicians to hear about the latest advances in research and novel treatments, and researchers to learn about new clinical needs and challenges.
The bid, spearheaded by Melbourne Convention Bureau (MCB) with support from the Victorian Government and Tourism Australia’s Business Events Bid Fund Program will contribute an estimated $5.9 million to the local economy and provide attendees unparalleled opportunities for communication, collaboration, and networking on an international scale.
"Our city's excellent infrastructure and collaborative partnerships spanning universities, research institutions, and hospitals have cultivated an environment where the world's most brilliant minds converge. It's a place where inspiration thrives, innovation flourishes, and tangible transformations emerge with world-leading research and development, says Melbourne Convention Bureau Chief Executive Julia Swanson.
“This synergy has undeniably propelled the city to the forefront of global destinations for hosting conferences within the medical and healthcare sector. When you choose Melbourne to host your conference, you are harnessing the extraordinary strengths of our city's unparalleled knowledge and innovation hub – a hub that resonates on a global scale.”
Melbourne's standing as a formidable force in medical research and innovation is enriched by the Victorian Government's strategic investments in pioneering medical precincts.
Neurosciences, including mental health, is one of the pillars of research excellence in the Melbourne Biomedical Precinct, with strengths across all facets of the drug development and commercialisation pipeline to become one of the world’s top drug discovery centres.
With more than 23,000 professionals engaged in the medical technologies and pharmaceuticals sector, Victoria boasts an impressive annual revenue of over $AU12.7 billion.
Professor Kazutaka Ikeda, the current President Elect of the International College of Neuropsychopharmacology, says: “We are thrilled that the congress will take place in Melbourne during his Presidential term and thank you the enormous support of the Melbourne Convention Bureau. The CINP World Congress of Neuropsychopharmacology offers an outstanding international platform to hear about the latest research advances, new treatments and clinical needs and challenges and to communicate, collaborate and network with a large international audience."
This accomplishment is amplified by Victoria's status as a nurturing environment for medical innovation. Home to a robust network of 22 pharmaceutical manufacturers, supported by 16 major medical research institutes, 11 renowned teaching hospitals, and nine prestigious universities, Victoria's influence within the healthcare realm is unequivocal.
Such distinction reinforces Melbourne's position as a coveted destination for global medical and healthcare conferences. The region's profound impact on the field, coupled with its unparalleled resources and collaborations, demonstrates Melbourne's reputation as a premiere host city for gatherings that shape the future of medical research, treatments, and advancements.
The congress programme, distinguished by its scientific rigor, will feature plenary lectures, pioneering scientific symposia, interactive poster sessions and a dedicated track for early career clinicians and researchers, including opportunities to network with global leaders in the field, as well as both educational and scientific workshops.
Tourism Australia Managing Director Phillipa Harrison says: “Tourism Australia’s Business Events Bid Fund continues to secure a strong pipeline of international business events across Australia, including this latest win for Melbourne. Hosting the CINP World Congress in Neuropsychopharmacology in Melbourne for the second time demonstrates that Australia continues to attract important international association meetings which will deliver significant benefits to the visitor economy.”
Supported by the Union of International Associations (UIA), the International Association of Professional Congress Organisers (IAPCO) and the Interel Group, the global public affairs and association management consultancy, Headquarters Magazines serve the needs of international associations organising worldwide congresses.